node1	node2	edge_score	
DB00937	SLC6A3	1.0	
DB00937	SLC6A2	1.0	
SLC6A2	rs5569	0.99
SLC6A2	rs12708954	0.99
SLC6A2		1.0
SLC6A3		1.0
SLC6A2	rs3785143	0.99
Behavior Disorders	SLC6A2	1.0	
Behavior Disorders	SLC6A3	1.0	
Heroin Dependence	SLC6A2	1.0	
Heroin Dependence	SLC6A3	1.0	
Methamphetamine abuse	SLC6A2	1.0	
Methamphetamine abuse	SLC6A3	1.0	
Anorexia nervosa 1	SLC6A2	1.0	
Anorexia nervosa 1	SLC6A3	1.0	
Tourette Syndrome	SLC6A2	1.0	
Tourette Syndrome	SLC6A3	1.0	
Lewy Body Disease	SLC6A2	1.0	
Lewy Body Disease	SLC6A3	1.0	
Borderline Personality Disorder	SLC6A2	1.0	
Borderline Personality Disorder	SLC6A3	1.0	
Anxiety	SLC6A2	1.0	
Anxiety	SLC6A3	1.0	
Bronchopulmonary Dysplasia	SLC6A2	1.0	
Bronchopulmonary Dysplasia	SLC6A3	1.0	
Pigmentary pallidal degeneration	SLC6A3	1.0	
Slow acetylator due to N-acetyltransferase enzyme variant	SLC6A2	1.0	
Autism spectrum disorders	SLC6A2	1.0	
Autism spectrum disorders	SLC6A3	1.0	
Dentinogenesis imperfecta	SLC6A2	1.0	
Recurrent major depressive episodes	SLC6A2	1.0	
Asthma, Occupational	SLC6A2	1.0	
Spinocerebellar ataxia 2	SLC6A3	1.0	
Bulimia	SLC6A3	1.0	
Paranoia	SLC6A3	1.0	
Delayed gross motor development	SLC6A3	1.0	
Orofacial cleft	SLC6A2	1.0	
Generalized anxiety disorder	SLC6A3	1.0	
Substance Use Disorders	SLC6A3	1.0	
Alcohol withdrawal syndrome	SLC6A3	1.0	
Motor symptoms	SLC6A3	1.0	
Systemic aspergillosis	SLC6A2	1.0	
 {Nicotine dependence, protection against}, 188890 (3)	SLC6A3	1.0	
Antisocial Personality Disorder	SLC6A3	1.0	
Cocaine delirium	SLC6A3	1.0	
Ataxic	SLC6A3	1.0	
Chronic schizophrenia	SLC6A3	1.0	
Mood Disorders	SLC6A2	1.0	
Mood Disorders	SLC6A3	1.0	
Personality disorder	SLC6A2	1.0	
Morphological abnormality of the pyramidal tract	SLC6A3	1.0	
Bulimia nervosa 1	SLC6A3	1.0	
Disseminated intravascular coagulation	SLC6A2	1.0	
Antisocial/borderline personality disorder	SLC6A3	1.0	
Substance abuse problem	SLC6A3	1.0	
Drug usage	SLC6A3	1.0	
Manic	SLC6A3	1.0	
Weight Loss Adverse Event	SLC6A2	1.0	
Conduct Disorder	SLC6A3	1.0	
Bradykinesia	SLC6A3	1.0	
Fibromyalgia	SLC6A3	1.0	
Anxiety Disorders	SLC6A2	1.0	
Anxiety Disorders	SLC6A3	1.0	
Abnormal autonomic nervous system physiology	SLC6A2	1.0	
Prenatal Exposure Delayed Effects	SLC6A3	1.0	
Respiratory tract infection	SLC6A2	1.0	
Respiratory tract infection	SLC6A3	1.0	
Unipolar Depression	SLC6A2	1.0	
Unipolar Depression	SLC6A3	1.0	
Cleft palate with cleft lip	SLC6A2	1.0	
Memory Disorders	SLC6A3	1.0	
Cocaine Dependence	SLC6A3	1.0	
Autoimmune lymphoproliferative syndrome, type 2	SLC6A3	1.0	
Mental disorders	SLC6A2	1.0	
Mental disorders	SLC6A3	1.0	
CNS symptom	SLC6A3	1.0	
As If Personality	SLC6A3	1.0	
Tardive Dyskinesia	SLC6A3	1.0	
Bipolar I disorder	SLC6A3	1.0	
Angelman syndrome-like	SLC6A3	1.0	
Psychoses, Substance-Induced	SLC6A3	1.0	
Attention Deficit Disorder	SLC6A3	1.0	
Colorectal polyposis	SLC6A2	1.0	
Drug Dependence	SLC6A3	1.0	
Atrial septal defect	SLC6A2	1.0	
Atrial septal defect	SLC6A3	1.0	
Osteochondritis dissecans	SLC6A3	1.0	
NEUROTICISM	SLC6A3	1.0	
Major depressive disorder	SLC6A2	1.0	
Major depressive disorder	SLC6A3	1.0	
Multiple Endocrine Neoplasia Type 2a	SLC6A2	1.0	
Well Differentiated Pancreatic Endocrine Tumor	SLC6A2	1.0	
MAJOR AFFECTIVE DISORDER 4	SLC6A3	1.0	
MAJOR AFFECTIVE DISORDER 5	SLC6A3	1.0	
MAJOR AFFECTIVE DISORDER 6	SLC6A3	1.0	
Major affective disorder 7	SLC6A3	1.0	
MAJOR AFFECTIVE DISORDER 8	SLC6A3	1.0	
MAJOR AFFECTIVE DISORDER 9	SLC6A3	1.0	
Orofacial dyskinesia	SLC6A3	1.0	
Eating disorder	SLC6A3	1.0	
Muscular hypotonia of the trunk	SLC6A3	1.0	
Migraine with aura	SLC6A3	1.0	
Ichthyosis bullosa of Siemens	SLC6A2	1.0	
Attention deficit hyperactivity disorder	SLC6A2	1.0	
Attention deficit hyperactivity disorder	SLC6A3	1.0	
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	SLC6A2	1.0	
Drug Allergy	SLC6A3	1.0	
Azorean disease	SLC6A3	1.0	
Substance addiction and disorders	SLC6A3	1.0	
Panic disorder 1	SLC6A2	1.0	
Depressive Disorder	SLC6A2	1.0	
Depressive Disorder	SLC6A3	1.0	
Growth Disorders	SLC6A3	1.0	
Multiple Endocrine Neoplasia Type 1	SLC6A2	1.0	
Gastrointestinal Diseases	SLC6A2	1.0	
{Unipolar depression, susceptibility to}, 608516 (3)	SLC6A2	1.0	
{Unipolar depression, susceptibility to}, 608516 (3)	SLC6A3	1.0	
Non-Hodgkin lymphoma	SLC6A2	1.0	
Non-Hodgkin lymphoma	SLC6A3	1.0	
Mitral Valve Prolapse	SLC6A2	1.0	
Amphetamine-Related Disorders	SLC6A3	1.0	
Candidiasis, familial, 9	SLC6A2	1.0	
Obsessive-compulsive disorder	SLC6A3	1.0	
Arterial thrombosis	SLC6A2	1.0	
Dyslexia 1	SLC6A3	1.0	
Cerebral palsy, spastic quadriplegic, 3	SLC6A2	1.0	
Alcohol abuse	SLC6A3	1.0	
Marijuana Abuse	SLC6A3	1.0	
Dyskinesia, seizures, and intellectual developmental disorder	SLC6A3	1.0	
Methicillin resistant Staphylococcus aureus	SLC6A2	1.0	
Shy-Drager syndrome	SLC6A3	1.0	
Hyperplastic Polyp	SLC6A2	1.0	
Rigidity	SLC6A3	1.0	
SUDDEN INFANT DEATH SYNDROME	SLC6A3	1.0	
Liver Cirrhosis, Alcoholic	SLC6A3	1.0	
Bacteremia, susceptibility to, 2	SLC6A2	1.0	
Posttraumatic stress disorder	SLC6A3	1.0	
Chorea, childhood-onset, with psychomotor retardation	SLC6A3	1.0	
Alcohol dependence	SLC6A2	1.0	
Alcohol dependence	SLC6A3	1.0	
Von Hippel-Lindau syndrome	SLC6A2	1.0	
CNS disorder	SLC6A3	1.0	
Nicotine Dependence	SLC6A3	1.0	
early pregnancy	SLC6A2	1.0	
Panic disorder syndrome 1 (2)	SLC6A2	1.0	
Cocaine-Related Disorders	SLC6A3	1.0	
Depressive Symptoms	SLC6A3	1.0	
Impotence	SLC6A3	1.0	
 {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	SLC6A2	1.0	
Neurodegeneration with brain iron accumulation	SLC6A3	1.0	
Abnormality of the autonomic nervous system	SLC6A2	1.0	
Abnormality of the peripheral nervous system	SLC6A2	1.0	
Bipolar affective disorder	SLC6A2	1.0	
Bipolar affective disorder	SLC6A3	1.0	
Tachycardia	SLC6A2	1.0	
Weight Gain Adverse Event	SLC6A3	1.0	
Neurofibromatosis, type 1, 162200 (3)	SLC6A2	1.0	
Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	SLC6A3	1.0	
Irritable bowel syndrome with diarrhea	SLC6A2	1.0	
Substance-Related Disorders	SLC6A3	1.0	
Amyotrophic lateral sclerosis type 1	SLC6A3	1.0	
Abnormality of extrapyramidal motor function	SLC6A3	1.0	
Dengue Fever	SLC6A2	1.0	
Secondary hyperparathyroidism	SLC6A2	1.0	
Carcinoid tumor	SLC6A2	1.0	
Vasculitis	SLC6A2	1.0	
Hypersensitivity	SLC6A3	1.0	
Adenocarcinoma of the large intestine	SLC6A2	1.0	
Progressive	SLC6A3	1.0	
Cycloid psychosis	SLC6A3	1.0	
Developmental delay with short stature, dysmorphic features, and sparse hair	SLC6A2	1.0	
